Search for: "In Re Ouellette"
Results 21 - 40
of 71
Sorted by Relevance
|
Sort by Date
21 Dec 2012, 2:36 am
Patent No. 5,581,243 on a "method and apparatus for displaying simulated keyboards on touch-sensitive displays" (first named inventor: Daniel Ouellette; application filed in June 1990)Japanese Patent Publication No. [read post]
7 May 2012, 2:10 pm
It’s a baffling decision. 512(f) Plaintiff Can’t Get Discovery to Back Up His Allegations of Bogus Takedowns–Ouellette v. [read post]
21 Mar 2014, 8:40 am
Eileen Ouellette, the president of the American Academy of pediatrics, given the fact that children are most frequently the victims of dangerous dog bites, it’s important to teach children about animal safety, but it’s also essential for families in general to make sure they’re taking the proper training and safety precautions around their pets. [read post]
7 Aug 2015, 1:39 pm
Lisa Larrimore Ouellette, Stanford Law School Collegiality/welcoming is a big benefit of coming here. [read post]
9 Aug 2018, 10:24 am
Madrid filing/Madrid filing in China (indicating a global strategy) is positively associated w/submarines b/c they’re worried about squatting in China.Daniel Hemel (and Lisa Larrimore Ouellette), Governing the Semantic CommonsSemantic space is elastic, but not infinitely or effortlessly so. [read post]
24 Apr 2010, 1:50 am
04/23/2010 By Jen Ouellette CAPE COD - State Rep. [read post]
1 Apr 2018, 3:56 am
Ouellette, "Does Running Out Of (Some) Trademarks Matter? [read post]
17 Mar 2020, 10:29 am
All the IP rights in the world would not do anything to stimulate investment if not enough people want or are willing or able to pay for what you're selling. [read post]
14 Mar 2014, 12:46 pm
But we’re not the only ones complaining. [read post]
2 Feb 2016, 12:24 pm
Recognizing that a failure to disclose conflicts of interest is a problem in law reviews, IPBiz notes that re-publishing of previous concepts, and the publishing of inaccurate information are both problems with some law reviews. [read post]
18 Aug 2021, 4:00 am
Ouellette et al v Law Society of Alberta, 2021 ABCA 283 [19] In addition, the adjudicator must be satisfied that the proposed appeal has a reasonable chance of success.[28] In the context of permission-to-appeal applications under rule 14.5(1)(a), a proposed appeal has a reasonable chance of success if the likelihood the appeal will succeed exceeds forty percent. [read post]
7 Apr 2020, 7:34 am
Furthermore, because drugs do expire, they’re not stockpiled when there’s a surplus. [read post]
27 May 2020, 12:00 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
10 Oct 2011, 3:14 am
K 4610 N43 2010 La preuve dans le re? [read post]
10 Sep 2016, 11:14 am
They’re not about source confusion. [read post]
2 Oct 2020, 7:10 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn recent weeks, a number of articles have reported great concern around the politicization of the approval process for future COVID-19 vaccines. [read post]
21 Apr 2020, 2:09 pm
They’re not perfect, but if they’re well fitted, they are effective at protecting the wearer (most crucially right now, the healthcare providers who are caring for patients and are themselves still getting sick in droves). [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
27 Apr 2020, 1:27 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
3 May 2021, 8:36 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWe have written before about the challenges of making decisions under scientific uncertainty and the simultaneous importance and difficulty of developing high-quality clinical evidence under pandemic circumstances. [read post]
